KetamineOne Capital Earnings Estimate

KetamineOne Capital Earnings per Share Projection vs Actual

About KetamineOne Capital Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of KetamineOne Capital earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current KetamineOne Capital estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as KetamineOne Capital fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada. Wellbeing Digital is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in KetamineOne Pink Sheet

KetamineOne Capital financial ratios help investors to determine whether KetamineOne Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KetamineOne with respect to the benefits of owning KetamineOne Capital security.